Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | APGE | LGND | ||
| Company | Eidos Therapeutics Inc | Apogee Therapeutics Inc | Ligand Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 77.10 | 229.43 | ||
| High | 128.49 | 80.24 | 234.09 | ||
| Low | 116.83 | 77.10 | 227.76 | ||
| Latest | 122.21 | 78.71 | 232.76 | ||
| Change | -6.23 | -0.59 | +2.98 | ||
| % Change | -4.85% | -0.74% | +1.30% | ||
| Volume | 335,500 | 1,113,600 | 185,100 | ||
| 20-Day Average Volume | 113,985 | 888,955 | 212,730 | ||
| Previous Close | 128.44 | 79.30 | 229.78 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 81.49 | 223.89 | ||
| 20-Day Raw Stochastic | 36.63% | 27.94% | 84.52% | ||
| 20-Day Relative Strength | 56.42 | 46.06 | 56.56 | ||
| Weighted Alpha | +136.62 | +71.39 | +101.77 | ||
| Today's Opinion | 88% Buy | 40% Buy | 96% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 96% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | -4.95% since 05/26/26 | -1.09% since 05/26/26 | ||
| Low | 116.83 on 01/25/21 | 75.86 on 05/27/26 | 222.76 on 06/01/26 | ||
| High | 131.08 on 01/20/21 | 85.99 on 05/27/26 | 238.76 on 05/27/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | -2.53% since 05/01/26 | +2.34% since 05/01/26 | ||
| Low | 116.24 on 01/05/21 | 75.00 on 05/21/26 | 200.01 on 05/07/26 | ||
| High | 132.54 on 01/04/21 | 88.28 on 05/11/26 | 238.76 on 05/27/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +10.99% since 03/02/26 | +14.91% since 03/02/26 | ||
| Low | 69.38 on 10/30/20 | 65.22 on 03/20/26 | 188.67 on 03/30/26 | ||
| High | 132.54 on 01/04/21 | 95.32 on 04/17/26 | 247.38 on 04/27/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +13.86% since 12/02/25 | +19.30% since 12/02/25 | ||
| Low | 38.44 on 07/31/20 | 60.35 on 02/09/26 | 175.89 on 01/13/26 | ||
| High | 132.54 on 01/04/21 | 95.32 on 04/17/26 | 247.38 on 04/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,872,384 | 4,664,743 | ||
| Shares Outstanding, K | 38,873 | 61,903 | 20,041 | ||
| Annual Sales | 26,690,000 | 0 | 268,090,000 | ||
| Annual Net Income | -37,840,000 | -255,840,000 | 124,450,000 | ||
| Last Quarter Sales | 130,000 | 0 | 51,720,000 | ||
| Last Quarter Net Income | -30,180,000 | -74,110,000 | -13,350,000 | ||
| 60-Month Beta | -0.16 | 0.62 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.06 on 05/11/26 | 1.63 on 05/07/26 | ||
| Earnings Date | 02/24/21 | 08/10/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | 2.500 on 04/03/07 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 31.18 | ||